Why is GMAB Down Today?
About Genmab A/S ADS
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the stan...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
Pharmaceutical Preparations sector: -0.3%
Market Comparison
🔔 Get GMAB Alerts
We'll notify you when GMAB's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
GMAB has moved more than 3.0% down on 16 occasions in the past year.
Frequently Asked Questions
Why is GMAB stock down today?
This stock is significantly underperforming its Pharmaceutical Preparations sector peers, suggesting a stock-specific catalyst.
Is GMAB stock a buy or sell right now?
Based on current analysis, GMAB shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the GMAB stock price target?
GMAB is currently trading at $52.10. Based on today's momentum, the expected short-term range is $50.54 - $53.14. See long-term price prediction →
Will GMAB stock continue falling?
Our analysis shows a 45% probability that GMAB's move continues in the next 1-3 days. Key level to watch: $49.49 (support).
Is GMAB stock oversold or overbought?
GMAB's RSI (Relative Strength Index) is currently at 60.3. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for GMAB stock?
GMAB's 10-day momentum indicator is at -4.75. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is GMAB outperforming or underperforming the market?
GMAB (-3.29%) is currently significantly underperforming the market (-2.9% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.
What does MACD indicate for GMAB?
GMAB's MACD (4.24) is currently below the signal line (4.55), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 45.4) is strong.
Is GMAB in an uptrend or downtrend?
Based on moving average analysis, GMAB is in a bullish trend. The price ($52.10) is trading above both the 20-day SMA ($49.28) and 50-day SMA ($40.81). This alignment typically indicates sustained upward momentum.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis